Recent insights into the mechanisms, predisposing factors, and racial differences of coronary vasospasm

Heart and Vessels

Volumn 20, Issue 1, 2005, Pages 1-7

  Miwa, Kunihisa ^a   Fujita, Masatoshi ^b   Sasayama, Shigetake ^a  

^a HAMAMATSU ROSAI HOSPITAL   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Coronary vasospasm; Dyslipidemia; Endothelial dysfunction; Endothelial nitric oxide synthase; Oxidative stress; Paraoxonase

Indexed keywords

ALPHA TOCOPHEROL; APOLIPOPROTEIN A1; ARGININE; ARYLDIALKYLPHOSPHATASE; CALCIUM; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLYCINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MAGNESIUM; MYOSIN LIGHT CHAIN PHOSPHATASE; NITRIC OXIDE; PROTEIN P22; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RHO KINASE;

ANGINA PECTORIS; ARTERIOGRAPHY; AUTONOMIC NERVOUS SYSTEM FUNCTION; BIOAVAILABILITY; CAUCASIAN; CELL PROLIFERATION; CIGARETTE SMOKING; COMPARATIVE STUDY; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY SPASM; DATA ANALYSIS; DISEASE ASSOCIATION; DISEASE MODEL; DISEASE PREDISPOSITION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME POLYMORPHISM; GENE DELETION; GENE EXPRESSION; GENE INSERTION; GENE MUTATION; HUMAN; HYPERSENSITIVITY; INCIDENCE; INFLAMMATION; JAPAN; LIPID METABOLISM; MAGNESIUM DEFICIENCY; METABOLIC DISORDER; MUSCLE CONTRACTION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHENOTYPE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; RACE DIFFERENCE; REVIEW; UPREGULATION; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

ASIAN CONTINENTAL ANCESTRY GROUP; CAUSALITY; CORONARY VASOSPASM; ENDOTHELIUM, VASCULAR; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; HYPERLIPIDEMIAS; MALE; NITRIC OXIDE SYNTHASE; OXIDATIVE STRESS; PROGNOSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SMOKING;

EID: 13844319454     PISSN: 09108327     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00380-004-0794-4     Document Type: Review

References (69)

1. Yasue H, Omote S, Takizawa A, Nagao M (1983) Coronary arterial spasm in ischemic heart disease and its pathogenesis. A review. Circ Res 52(suppl I):147-159
2. Nakamura M, Takeshita A, Nose Y (1987) Clinical characteristics associated with myocardial infarction, arrhythmias, and sudden death in patients with vasospastic angina. Circulation 75:1110-1118
3. Sugiishi M, Takatsu F (1993) Cigarette smoking is a major risk factor for coronary spasm. Circulation 87:76-79
4. Shimokawa H, Nagasawa K, Irie T, Egashira S, Egashira K, Sagara T, Kikuchi Y, Nakamura M (1988) Clinical characteristics and long-term prognosis of patients with variant angina. A comparative study between western and Japanese populations. Int J Cardiol 18:331-349
5. Pristipino C, Beltrame JF, Finocchiaro ML, Hattori R, Fujita M, Mongiardo R, Cianflone D, Sanna T, Sasayama S, Maseri A (2000) Major racial differences in coronary constrictor response between Japanese and Caucasians with recent myocardial infarction. Circulation 101:1102-1108
6. Beltrame JF, Sasayama S, Maseri A (1999) Racial heterogeneity in coronary artery vasomotor reactivity: Differences between Japanese and Caucasian patients. J Am Coll Cardiol 33:1444-1452
7. Kugiyama K, Yasue H, Okumura K, Ogawa H, Fujimoto K, Nakao K, Yoshimura M, Motoyama T, Inobe Y, Kawano H (1996) Nitric oxide activity is deficient in spasm arteries of patients with coronary spastic angina. Circulation 94:266-272
8. Egashira K, Katsuda Y, Mohri M, Kuga T, Tagawa T, Shimokawa H, Takeshita A (1996) Basal release of endothelium-derived nitric oxide at site of spasm in patients with variant angina. J Am Coll Cardiol 27:1444-1449
9. Miwa K, Igawa A, Inoue H (1997) Soluble E-selectin, ICAM-1 and VCAM-1 levels in systemic and coronary circulation in patients with variant angina. Cardiovasc Res 36:37-44
10. Motoyama T, Kawano H, Kugiyama K, Hirashima O, Ohgushi M, Tsunoda R, Moriyama Y, Miyao Y, Yoshimura M, Ogawa H, Yasue H (1998) Vitamin E administration improves impairment of endothelium-dependent vasodilation in patients with coronary spastic angina. J Am Coll Cardiol 32:1672-1679
11. Yasue H, Kugiyama K (2000) Coronary artery spasm. Clinical features, pathogenesis and treatment. In: Yasue H (ed) Coronary artery spasm. Springer, Berlin Heidelberg New York Tokyo, pp 9-18
12. Somlyo AP, Somlyo AV (1994) Signal transduction and regulation in smooth muscle. Nature 372:231-236
13. Hernández-Presa M, Bustos C, Ortega M, Tuõn J, Renedo G, Ruiz-Ortega M, Egido J (1997) Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-κ B activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis. Circulation 95:1532-1541
14. Barnes PJ, Karin M (1997) Mechanisms of disease: Nuclear factor-κ B: pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336:1041-1045
15. Shimokawa H, Ito A, Fukumoto Y, Kadokami T, Nakaike R, Sakata M, Takayanagi T, Egashira K, Takeshita A (1996) Chronic treatment with interleukin-1β induces coronary intimal lesions and vasospastic responses in pigs in vivo. The role of platelet-derived growth factor. J Clin Invest 97:769-776
16. Ito A, Shimokawa H, Nakaike R, Fukai T, Sakata M, Takayanagi T, Egashira K, Takeshita A (1994) Role of protein kinase C-mediated pathway in the pathogenesis of coronary artery spasm in a swine model. Circulation 90:2425-2431
17. Kadokami T, Shimokawa H, Fukumoto Y, Ito A, Takayanagi T, Egashira K, Takeshita A (1996) Coronary artery spasm does not depend on the intracellular calcium store but is substantially mediated by the protein kinase C-mediated pathway in a swine model with interleukin-1β in vivo. Circulation 94:190-196
18. Kandabashi T, Shimokawa H, Miyata K, Kunihira I, Kawano Y, Fukaya Y, Higo T, Egashira K, Takahashi S, Kaibuchi K, Takeshita A (2000) Inhibition of myosin phosphatase by upregulated Rho-kinase plays a key role for coronary artery spasm in a porcine model with Interleukin-1β. Circulation 101:1319-1323
19. Miwa K, Miyagi Y, Fujita M (1995) Susceptibility of plasma low density lipoprotein to cupric ion-induced peroxidation in patients with variant angina. J Am Coll Cardiol 26:632-638
20. Miwa K, Miyagi Y, Igawa A, Nakagawa K, Inoue H (1996) Vitamin E deficiency in variant angina. Circulation 94:14-18
21. Miwa K, Kishimoto C, Nakamura H, Makita T, Ishii K, Okuda N, Taniguchi A, Shioji K, Yodoi J, Sasayama S (2003) Increased oxidative stress with elevated serum thioredoxin level in patients with coronary spastic angina. Clin Cardiol 26:177-181
22. Miwa K, Okinaga S, Fujita M (2004) Low serum α-tocopherol levels in subjects with various coronary risk factors. Circ J 68:542-546
23. Yasue H, Takizawa A, Nagao M, Nishida S, Horie M, Kubota J, Omote S, Takapka K, Okumura K (1988) Long-term prognosis for patients with variant angina and influential factors. Circulation 78:1-9
24. Takaoka K, Yoshimura M, Ogawa H, Kugiyama K, Nakayama M, Shimasaki Y, Mizuno Y, Sakamoto T, Yasue H (2000) Comparison of the risk factors for coronary artery spasm with those for organic stenosis in a Japanese population: Role of cigarette smoking. Int J Cardiol 72:121-126
25. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL (1989) Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 320:915-924
26. Murohara T, Kugiyama K, Ohgushi M, Sugiyama S, Yasue H (1994) Cigarette smoking extract contracts isolated porcine coronary arteries by superoxide anion-mediated degradation of EDRF. Am J Physiol 266:H874-H880
27. 2-isoprostanes) in smokers as a cause of oxidative damage. N Engl J Med 332:1198-1203
28. Miwa K, Fujita M, Miyagi Y (1994) Beneficial effects of smoking cessation on the short-term prognosis of variant angina validation of the smoking status by urinary cotinine measurements. Int J Cardiol 44:151-156
29. Sakata N, Moh A, Takebayashi S (2002) Contribution of superoxide to reduced antioxidant activity of glycoxidative serum albumin. Heart Vessels 17:22-29
30. Shimabukuro H, Shinzato T, Higa S, Chibana T, Yoshida H, Nagamine F, Murakami K, Takasu N (1995) Enhanced insulin response relates to acetylcholine-induced vasoconstriction in vasospastic angina. J Am Coll Cardiol 25:356-361
31. Suzuki M, Nishizaki M, Arita M, Kakuta T, Numano F (1996) Impaired glucose tolerance with late hypersecretion of insulin during oral glucose tolerance test in patients with vasospastic angina. J Am Coll Cardiol 27:1458-1463
32. Shinozaki K, Suzuki M, Ikebuchi M, Takaki H, Hara Y, Tsushima M, Harano Y (1995) Insulin resistance associated with compensatory hyperinsulinemia as an independent risk factor for vasospastic angina. Circulation 92:1749-1757
33. Miwa K, Fujita M, Miyagi Y, Inoue H, Sasayama S (1995) High-density lipoprotein cholesterol level and smoking modify the prognosis of patients with coronary vasospasm. Clin Cardiol 18:267-272
34. Miwa K, Yoshida N, Nakagawa K, Inoue H (1998) High-density lipoprotein particles are large in patients with variant angina. Cardiovasc Res 37:729-737
35. Miwa K, Igawa A, Nakagawa K, Hirai T, Inoue H (1999) Consumption of vitamin E in coronary circulation in patients with variant angina. Cardiovasc Res 41:291-298
36. Miwa K, Nakagawa K, Suzuki K, Inoue H (2001) Detection of the "Midband" lipoprotein in patients with coronary artery spasm. Clin Cardiol 24:219-224
37. Miwa K (2003) Low density lipoprotein particles are small in patients with coronary vasospasm. Int J Cardiol 87:193-201
38. Miwa K, Makita T, Ishii K, Okuda N, Taniguchi A (2004) High remnant lipoprotein levels in patients with variant angina. Clin Cardiol 27:338-342
39. Kugiyama K, Doi H, Motoyama T, Soejima H, Misumi K, Kawano K, Nakagawa O, Yoshimura M, Ogawa H, Matsumura T, Sugiyama S, Nakano T, Nakajima K, Yasue H (1998) Association of remnant lipoprotein levels with impairment of endothelium-dependent vasomotor function in human coronary arteries. Circulation 97:2519-2526
40. Miwa K, Nakagawa K, Yoshida N, Taguchi Y, Inoue H (2000) Lipoprotein(a) is a risk factor for occurrence of acute myocardial infarction in patients with coronary vasospasm. J Am Coll Cardiol 35:1200-1205
41. -786 → C mutation in the 5-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 99:2864-2870
42. -786 → C mutation in the 5-flanking region of the endothelial nitric oxide synthase gene is associated with myocardial infarction, especially without coronary organic stenosis. Am J Cardiol 86:628-634
43. Yoshimura M, Yasue H, Nakayama M, Shimasaki Y, Sumida H, Sugiyama S, Kugiyama K, Ogawa H, Ogawa Y, Saito Y, Miyamoto Y, Nakao K (1998) A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese. Hum Genet 103:65-69
44. Wang XL, Sim AS, Badenhop RF, McCredie RM, Wilcken DEL (1996) A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nat Med 2:41-45
45. Miwa K, Toda N (1984) Regional differences in the response to vasoconstrictor agents of dog and monkey isolated coronary arteries. Br J Pharmacol 82:295-301
46. Oike Y, Hata A, Ogata Y, Numata Y, Shido K, Kondo K (1995) Angiotensin converting enzyme as a genetic risk factor for coronary artery spasm. J Clin Invest 96:2975-2979
47. Matsumoto K, Morishita R, Tomita N, Moriguchi A, Komai N, Aoki M, Matsumoto K, Nakamura T, Higaki J, Ogihara T (2003) Improvement of endothelial dysfunction by angiotensin II blockade accompanied by induction of vascular hepatocyte growth factor system in diabetic spontaneously hypertensive rats. Heart Vessels 18:18-25
48. Higashi M, Shimokawa H, Hattori T, Hiroki J, Mukai Y, Morikawa K, Ichiki T, Takahashi S, Takeshita A (2003) Long-term inhibition of Rho-kinase suppresses angiotensin II-induced cardiovascular hypertrophy in rats in vivo. Effect on endothelial NAD(P)H oxidase system. Circ Res 93:767-775
49. 2 in angiotensin II-induced vascular hypertrophy. Hypertension 32:488-495
50. Kathy K, Minieri CA, Ollerenshaw JD, Wayne Alexander R (1994) Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 74:1141-1148
51. Inoue N, Kawashima S, Kanazawa K, Yamada S, Akita H, Yokoyama M (1998) Polymorphism of the NADH/NADPH oxidase p22 phox gene in patients with coronary artery desease. Circulation 97:135-137
52. phox in human coronary arteries. Circulation 100:1494-1498
53. Mackness B, Durrington PN, Mackness MI (1999) Polymorphisms of paraoxonase genes and low-density lipoprotein lipid peroxidation. Lancet 353:468-469
54. 192 isoform paraoxonase with low sarin-hydrolyzing activity is dominant in the Japanese. Hum Genet 101:67-68
55. Bauters C, Amant C, Boulier A, Cabrol P, McFadden E, Duriez P, Bertrand ME, Amouyel P (2000) Paraoxonase polymorphism (Gln192Arg) as a determinant of response of human coronary arteries to serotonin. Circulation 101:740-743
56. Ito T, Yasue H, Yoshimura M, Nakamura S, Nakayama M, Shimasaki Y, Harada E, Mizuno Y, Kawano H, Ogawa H (2002) Paraoxonase gene Gln192Arg(Q192R) polymorphism is associated with coronary artery spasm. Hum Genet 110:89-94
57. Yasue H, Touyama M, Kato H, Tanaka S (1974) Role of autonomic nervous system in the pathogenesis of Prinzmetal's variant angina. Circulation 50:534-539
58. Yasue H, Omote S, Takizawa A, Nagao M, Miwa K, Tanaka S (1979) Circadian variation of exercise capacity in patients with Prinzmetal's variant angina: Role of exercise-induced coronary arterial spasm. Circulation 59:938-948
59. Yasue H, Horio Y, Nakamura N, Fujii H, Imoto N, Sonoda R, Kugiyama K, Obata K, Morikami Y, Kimura T (1986) Induction of coronary artery spasm by acetylcholine in patients with variant angina: Possible role of the parasympathetic nervous system in the pathogenesis of coronary artery spasm. Circulation 74:955-963
60. Miwa K, Igawa A, Miyagi Y, Nakagawa K, Inoue H (1998) Alterations of autonomic nervous activity preceding nocturnal variant angina: sympathetic augmentation with parasympathetic impairment. Am Heart J 135:762-771
61. Miwa K, Goto M, Lee JD, Matsuyama F, Shimizu H, Kato T, Hara A, Nakamura T (1988) Supersensitivity of coronary arteries in variant angina to spasm induced by intracoronary acetylcholine. Am J Cardiol 61:77-82
62. Miwa K, Fujita M, Ejiri M, Sasayama S (1990) Comparative sensitivity of intracoronary injection of acetylcholine for the induction of coronary spasm in patients with various types of angina pectoris. Am Heart J 120:544-550
63. Yoshio H, Shimizu M, Sugihara N, Kita Y, Shimizu K, Minagawa F, Nakabayashi H, Takeda R (1993) Assessment of autonomic nervous activity by heart rate spectral analysis in patients with variant angina. Am Heart J 125:324-329
64. Ooie T, Takakura T, Shiraiwa H, Yoshimura A, Hara M, Saikawa T (1998) Changes in heart rate variability preceding ST elevation in a patient with vasospastic angina pectoris. Heart Vessels 13:40-44
65. Miyagi H, Yasue H, Okumura K, Ogawa H, Goto K, Oshima S (1989) Effect of magnesium on anginal attack induced by hyperventilation in patients with variant angina. Circulation 79:597-602
66. Goto K, Yasue H, Okumura K, Matsuyama K, Kugiyama K, Miyagi H, Higashi T (1990) Magnesium deficiency detected by intravenous loading test in variant angina pectoris. Am J Cardiol 65:709-712
67. Miwa K, Igawa A, Miyagi Y, Fujita M (1994) Importance of magnesium deficiency in alcohol-induced variant angina. Am J Cardiol 73:813-816
68. Igawa K, Miwa K, Miyagi Y, Fujita M, Inoue H (1995) Comparison of frequency of magnesium deficiency in patients with vasospastic angina and fixed coronary artery disease. Am J Cardiol 75:728-731
69. Takizawa A, Yasue H, Omote S, Nagao M, Hyon H, Nishida S, Horie M (1984) Variant angina induced by alcohol ingestion. Am Heart J 107:25-27